(Q35977131)

11 August 2017

PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases (English)

1 reference

11 August 2017

M Gion

1

1 reference

11 August 2017

R Mione

2

1 reference

11 August 2017

G L Pappagallo

3

1 reference

11 August 2017

C Gatti

4

1 reference

11 August 2017

O Nascimben

5

1 reference

11 August 2017

M Bari

6

1 reference

11 August 2017

A E Leon

7

1 reference

11 August 2017

O Vinante

8

1 reference

11 August 2017

G Bruscagnin

9

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

68

1 reference

11 August 2017

2

1 reference

11 August 2017

374-379

1 reference

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Progesterone receptors as a prognostic factor in Stage II breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Estrogen regulation of specific proteins as a mode of hormone action in human breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Prediction of relapse and survival in breast cancer patients by pS2 protein status

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

The pS2 gene, mRNA, and protein: a potential marker for human breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Steroid receptors in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Breast screening, prognostic factors and survival – results from the Swedish two county study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Natural history of human breast cancer: Recent data and clinical implications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Tumor cell heterogeneity: an overview

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Cathepsin D and prognosis in breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

Influence of estrogen receptor variants in mammary carcinomas on the prognostic reliability of the receptor assay

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968537

On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18, and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum

24 September 2018

1 reference

12 December 2020

pS2 expression and response to hormonal therapy in patients with advanced breast cancer

1 reference

12 December 2020

Variant human breast tumor estrogen receptor with constitutive transcriptional activity

1 reference

12 December 2020

Hormone Receptors as Prognostic Factors in Female: Breast Cancer

1 reference

12 December 2020

Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor

1 reference

12 December 2020

Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.343

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

8347494

1 reference